The Early Impact of COVID-19 on Chronic Pain: A Cross-Sectional Investigation of a Large Online Sample of Individuals with Chronic Pain in the United States, April to May, 2020.
The Early Impact of COVID-19 on Chronic Pain: A Cross-Sectional Investigation of a Large Online Sample of Individuals with Chronic Pain in the United States, April to May, 2020.
复制标题
DOI：
10.1093/pm/pnaa446
复制
发表时间：
2021-02-23
期刊：
影响因子：
--
通讯作者：
Aaron RV
中科院分区：
文献类型：
--
作者：
Mun CJ;Campbell CM;McGill LS;Aaron RV
慢性疼痛患者受到新冠肺炎大流行的独特挑战，因为增加的压力可能会加剧慢性疼痛，而且接受慢性疼痛治疗有新的障碍。有鉴于此，我们利用美国的大量在线样本，研究了1)新冠肺炎对疼痛严重程度、疼痛干预和慢性疼痛管理的早期影响；以及2)与疼痛严重程度和疼痛干预感知变化相关的变量。一项横断面研究。通过亚马逊的机械土耳其平台收集了1453名患有慢性疼痛的成年人的在线调查数据。虽然很大比例的参与者报告说，自疾病爆发以来，他们的疼痛严重程度和疼痛干预没有明显的变化，但大约25%-30%的人报告这些领域的恶化。被认为是黑人和非西班牙裔血统的人，他们的情绪和睡眠质量受到的干扰更大，报告疼痛干扰恶化的可能性更大。大多数参与者报告说，他们像往常一样采取自我管理策略。然而，大多数慢性疼痛治疗的预约要么被推迟，要么被取消，未来没有安排会议。此外，相当比例的参与者对新冠肺炎导致的处方阿片类药物感到担忧或难以获得。我们可能会看到，受大流行影响最大的个人中，慢性疼痛的长期恶化以及对功能和慢性疼痛管理的相关干预。这些人可能受益于远程提供的干预措施，以有效缓解新冠肺炎相关的慢性疼痛加剧和面对面治疗中断。
Individuals with chronic pain are uniquely challenged by the COVID-19 pandemic, as increased stress may exacerbate chronic pain, and there are new barriers to receiving chronic pain treatment. In light of this, using a large online sample in the United States, we examined 1) the early impact of COVID-19 on pain severity, pain interference, and chronic pain management; and 2) variables associated with perceived changes in pain severity and pain interference. A cross-sectional study. Online survey data for 1,453 adults with chronic pain were collected via Amazon’s Mechanical Turk platform. Although a large proportion of participants reported no perceived changes in their pain severity and pain interference since the outbreak, approximately 25–30% of individuals reported exacerbation in these domains. Individuals identifying as Black and of non-Hispanic origin, who experienced greater disruptions in their mood and sleep quality, were more likely to report worsened pain interference. The majority of participants reported engaging in self-management strategies as usual. However, most appointments for chronic pain treatment were either postponed or canceled, with no future session scheduled. Furthermore, a notable proportion of participants had concerns about or difficulty accessing prescription opioids due to COVID-19. We may expect to see a long-term exacerbation of chronic pain and related interference in functioning and chronic pain management among individuals most impacted by the pandemic. These individuals may benefit from remotely delivered intervention to effectively mitigate COVID-19–related exacerbations in chronic pain and interruptions in face-to-face treatment.
登录
查看更多内容
影响因子：
5.4
作者：
Shevlin M;McBride O;Murphy J;Miller JG;Hartman TK;Levita L;Mason L;Martinez AP;McKay R;Stocks TVA;Bennett KM;Hyland P;Karatzias T;Bentall RP
通讯作者：
Bentall RP
影响因子：
7.4
作者：
Riley, JL;Wade, JB;Price, DD
通讯作者：
Price, DD
COVID-19 相关政策变化对阿片类药物和苯二氮卓类药物灌装的影响。
DOI：
10.1016/j.sapharm.2020.06.003
发表时间：
2021-01
期刊：
Research in social & administrative pharmacy : RSAP
影响因子：
--
作者：
Downs CG;Varisco TJ;Bapat SS;Shen C;Thornton JD
通讯作者：
Thornton JD
影响因子：
4
作者：
Finan, Patrick H.;Goodin, Burel R.;Smith, Michael T.
通讯作者：
Smith, Michael T.
影响因子：
4
作者：
Scott, Whitney;McCracken, Lance M.
通讯作者：
McCracken, Lance M.